This study is testing whether a new medication called AR882 can effectively lower uric acid levels and reduce painful gout attacks. It involves 750 people with gout who will take either AR882 or a placebo for 12 months. Researchers want to see if AR882 helps prevent gout flares a…
Phase: PHASE3 • Sponsor: Arthrosi Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 03:41 UTC